[Epidemiology of hepatitis B and C in Croatia]

Vladimira Lesnikar1

  • 1Zavod za javno zdravstvo grada Zagreba, Mirogojska cesta 16, 10000 Zagreb, Hrvatska vladimira.lesnikar@zg.htnet.hr

Insights

Hepatitis B (HBV) and Hepatitis C (HCV) infections are difficult to track due to asymptomatic cases. Croatia has low HBsAg carrier rates, with infections primarily spreading among young adults through sexual contact or skin exposure.

Area of Science:

  • Hepatology and Virology
  • Infectious Disease Epidemiology
  • Public Health Surveillance

Context:

  • Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections present diagnostic challenges due to a significant number of asymptomatic cases.
  • Croatia reports approximately 200 new HBV infections and HBsAg carriers annually, with a general population HBsAg carrier rate below 2%.
  • HCV infection markers (anti-HCV) prevalence exceeds 1% in Croatia, with around 200 reported cases yearly, predominantly in the 20-40 age group.

Purpose:

  • To determine the incidence and prevalence of Hepatitis B and C infections in Croatia.
  • To identify high-risk populations and transmission routes for HBV and HCV.
  • To inform public health strategies for infection control and prevention.

Summary:

  • HBV predominantly affects adolescents and young adults via sexual or percutaneous routes, with specific high-risk groups identified (e.g., IV drug users, newborns of infected mothers).
  • HCV incidence is highest in the 20-40 age group, primarily linked to intravenous drug use and historical blood transfusions before screening.
  • Data from the Croatian Institute of Public Health indicates consistent annual infection numbers for both HBV and HCV, highlighting ongoing transmission.

Impact:

  • Understanding transmission dynamics is crucial for targeted prevention programs in Croatia.
  • Highlights the need for continued vigilance and screening, especially in identified high-risk populations.
  • Provides baseline data for evaluating the effectiveness of public health interventions against viral hepatitis.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...